Testing a drug that may help find tumors during brain surgery in children
Official title: Panitumumab-IRDye800 to Detect Pediatric Neoplasms During Neurosurgical Procedures
Status: Recruiting. It is looking for patients now. Talk to your care team about whether it fits you.
The trial team last updated this record on .
The short version
Doctors are testing if a drug called panitumumab-IRDye800 is safe for children during brain surgery.
Read our full plain-language summary
What the trial team says
The objective of the study is to assess safety of panitumumab-IRDye800 in pediatric patients undergoing brain surgery to remove suspected tumors.
Key facts
- Registry number
- NCT04085887
- Stage of testing
- Phase 1/Phase 2
- Conditions studied
- Brain Tumor
Where it is running
This trial lists 1 site.
-
California
- Stanford Cancer Center (Stanford)
How to use this
Talk to your care team first. They know your history and can tell you whether this trial is worth your time.
Joining a trial is always your choice. A trial is a test, not a proven treatment. Being in one is not a promise that it will help you.
This page is built from the trial's listing on ClinicalTrials.gov, a service of the U.S. National Library of Medicine. That listing is the authority, and it may have changed since we last read it. We do not run this trial and we cannot enroll you in it.